oxypeucadanin has been researched along with Innate Inflammatory Response in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
| Du, L; Jia, Y; Kan, X; Li, C; Meng, G; Wang, Q; Zhang, J; Zhang, X | 1 |
2 other study(ies) available for oxypeucadanin and Innate Inflammatory Response
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Oxypeucedanin relieves LPS-induced acute lung injury by inhibiting the inflammation and maintaining the integrity of the lung air-blood barrier.
Topics: Acute Lung Injury; Anti-Inflammatory Agents; Blood-Air Barrier; Furocoumarins; Humans; Inflammation; Lipopolysaccharides; Lung; NF-kappa B; Peroxidase; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt | 2022 |